---
layout: double
title: "New publication: Pharmacological CDK46 inhibition promotes vulnerability to lysosomotropic agents in breast cancer"
date: 2025 Feb 10
thumbnail: "'/assets/posts/pubmed_39930269.png'"
---
<strong>"Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer."</strong> by <em>Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, <strong>Demaria M</strong></em>  has been just published in <em><strong><ins>EMBO J</ins></strong></em>.
Congratulations to the authors!
    
PubMed ID: 39930269
    
[https://pubmed.ncbi.nlm.nih.gov/39930269/](https://pubmed.ncbi.nlm.nih.gov/39930269)
![](/assets/posts/pubmed_39930269.png)
